Form 4: Arrow Financial Corp Executive Acquires Shares Through Restricted Stock Grant
SEC Form 4 Filing
Brooke M. Pancoe, EVP and Chief HR Officer of Arrow Financial Corp, acquired 823 shares of common stock through a restricted stock grant that vests over four years.
Summary
- On May 29, 2024, Brooke M. Pancoe, EVP and Chief HR Officer of Arrow Financial Corp, acquired 823 shares of common stock.
- The acquisition was through a restricted stock grant.
- The restricted stock vests 25% per year, starting on May 29, 2025, and continuing on May 29, 2026, May 29, 2027, and May 29, 2028.
- Following the transaction, Pancoe directly owns 1,336 shares of common stock.
- Pancoe also indirectly owns 25 shares held by a spouse, but disclaims beneficial ownership of these shares.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The acquisition of shares by an executive is generally a good sign, indicating confidence in the company. The vesting schedule promotes long-term commitment.
Positives
- The acquisition of shares by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
- The vesting schedule of the restricted stock encourages long-term commitment from the executive.
Future Outlook
The vesting schedule of the restricted stock suggests a long-term commitment from the executive to the company's success.
Industry Context
Executive stock ownership is a common practice in the financial industry to align management's interests with those of shareholders.
Stakeholder Impact
- The transaction could have a slightly positive impact on shareholders, as it signals confidence from a key executive.
- The vesting schedule may incentivize the executive to work towards the long-term success of the company, benefiting employees and other stakeholders.
Key Dates
| Date | Description |
|---|---|
| 05/29/2024 | Date of transaction: acquisition of 823 shares of common stock. |
| 05/29/2025 | First vesting date for 25% of the restricted stock. |
| 05/29/2026 | Second vesting date for 25% of the restricted stock. |
| 05/29/2027 | Third vesting date for 25% of the restricted stock. |
| 05/29/2028 | Final vesting date for 25% of the restricted stock. |
| 05/30/2024 | Date of signature by Attorney in Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.